Skip to content
★ Sign in to follow
GM

Graham Mullis, Chief Executive Officer

Novacyt S.A.
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€591k
▼ Sales (0 ops.)
—

Latest filing published 12 Nov 2020 for Novacyt S.A., €558k.

Filing timeline

BuySale
Graham Mullis, Chief Executive Officer

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-11.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Nov 2020 · 2187 days ago · €558k
    -74.5%
    Entry £8.97 · Close at T+365 £2.29
  • Filed 18 May 2020 · 2365 days ago · €33k
    +26.2%
    Entry £3.33 · Close at T+365 £4.20

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Graham Mullis, Chief Executive Officer: trading record in brief

This profile gathers the share dealings of Graham Mullis, Chief Executive Officer in Novacyt S.A. The record holds 2 filings, for trades running from 15 May 2020 to 11 November 2020.

No open-market sale appears; the market trades are 2 purchases worth €591k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 12 November 2020 came the latest disclosure, an open-market purchase for €558k in Novacyt S.A. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Graham Mullis, Chief Executive Officer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    See 1(a) - classified as a PDMR of the CompanyExecutivesNovacyt S.A.
    497,349 GBP31FCA-NSM
    60,875 shares@ £8.1794.4% of flowLondon Stock Exchange, AIMISIN FR0010397232FCA-NSM:3777892
    Canonical exit: 9 Feb 2021 (T+90)
  • ▲
    See 1(a) - classified as a PDMR of the CompanyExecutivesNovacyt S.A.
    29,428 GBP24FCA-NSM
    9,493 shares@ £3.105.6% of flowAIMISIN FR0010397232FCA-NSM:3598195-0
    Canonical exit: 13 Aug 2020 (T+90)

2 of 2 declarations